With relevance to brain disease, SORLA acts as a sorting receptor for APP, moving internalized APP from endosomes retrogradely to the TGN to prevent its breakdown into amyloid-β peptides in early endosomes (Andersen et al., 2005; Burgert et al., 2013; Dumanis et al., 2015). This evidence concerns the gene APP and brain disorder.